Open access · CC-BY
via OpenAlex
Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies
Neurobiology of Disease · 2024 · ▲ 9 citations
Abstract
Parkinson's disease (PD), the second most common neurodegenerative disease worldwide, is marked by the presence of Lewy bodies and Lewy neurites, neuronal lesions containing large amounts of the synaptic protein alpha-synuclein (αS). While the underlying mechanisms of disease progression in PD remain unclear, increasing evidence supports the importance of interactions between αS and cellular membranes in PD pathology. Therefore, understanding the αS-membrane interplay in health and disease is crucial for the development of therapeutic strategies. In this review, we (1) discuss key scenarios of pathological αS-membrane interactions; (2) present in detail therapeutic strategies explicitly reported to modify αS-membrane interactions; and (3) introduce additional therapeutic strategies that may involve aspects of interfering with αS-membrane interaction. This way, we aim to provide a holistic perspective on this important aspect of disease-modifying strategies for PD and other α-synucleinopathies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.nbd.2024.106646
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Li, B., & Dettmer, U. (2024). Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies. <em>Neurobiology of Disease</em>. https://doi.org/10.1016/j.nbd.2024.106646
Vancouver
Li B, Dettmer U. Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies. Neurobiology of Disease. 2024. doi:10.1016/j.nbd.2024.106646.
BibTeX
@article{baoyi2024Intera,
title = {Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies},
author = {Baoyi Li and Ulf Dettmer},
journal = {Neurobiology of Disease},
year = {2024},
doi = {10.1016/j.nbd.2024.106646},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neurodegenerative Diseases 2020
Open access · OA
Alpha-Synuclein: The Interplay of Pathology, Neuroinflammation, and Environmental Factors in Parkinson’s Disease
Cells 2022
Open access · CC-BY
Alpha-Synuclein Aggregation Pathway in Parkinson’s Disease: Current Status and Novel Therapeutic Approaches
ADMET & DMPK 2026
Open access · CC-BY
Alpha-synuclein pathobiology and therapeutic targeting in Parkinson’s disease
Molecular Neurodegeneration 2023
Open access · CC-BY
Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
Experimental Neurobiology 2014
Open access · OA
Alpha-Synuclein Function and Dysfunction on Cellular Membranes
Frontiers in Neuroscience 2020
Open access · CC-BY